MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Modafinil

Modafinil 100mg tablets

Use with caution

Stability notes for Modafinil 100mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Provigil 100mg tablets (Teva Pharma BV) and Modafinil 100mg tablets (Aurobindo Pharma – Milpharm Ltd).

Suppliers (7) of Modafinil 100mg tablets
Modafinil 100mg tablets (A A H Pharmaceuticals Ltd)
Modafinil 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Modafinil 100mg tablets (Drugsrus Ltd)
Modafinil 100mg tablets (Medihealth (Northern) Ltd)
Modafinil 100mg tablets (Milpharm Ltd)
Incompatible
Modafinil 100mg tablets (Sigma Pharmaceuticals Plc)
Provigil 100mg tablets (Sigma Pharmaceuticals Plc)

Modafinil 200mg tablets

Use with caution

Stability notes for Modafinil 200mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.  No stability data in MCAs available.

Provenance

This recommendation is based on the product Modafinil 200mg tablets (Aurobindo Pharma – Milpharm Ltd).

Suppliers (8) of Modafinil 200mg tablets
Modafinil 200mg tablets (A A H Pharmaceuticals Ltd)
Modafinil 200mg tablets (Accord-UK Ltd)
Modafinil 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Modafinil 200mg tablets (Crescent Pharma Ltd)
Modafinil 200mg tablets (Drugsrus Ltd)
Modafinil 200mg tablets (Medihealth (Northern) Ltd)
Modafinil 200mg tablets (Milpharm Ltd)
Modafinil 200mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.